Effectiveness of antimalarial drugs [1] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 4, 2005, Pages 420-422

  Gerrish, Stephen J ^a   De Koning, Laura ^b   Smego Jr , Raymond A ^c   Croft, Ashley M ^d   Beer, Michael D ^e   Herxheimer, Andrew ^f   Baird, J Kevin ^g,h  

^a Kara Counselling   (Zambia)

^b National Institute of Allergy and Infectious Diseases ^*  (Netherlands)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d British Forces Germany Health Service   (Germany)

^e UNIVERSITY OF LONDON   (United Kingdom)

^f UK COCHRANE CENTRE   (United Kingdom)

^g US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^h American Embassy Jakarta   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DOXYCYCLINE; FANSIDAR; MEFLOQUINE; PROGUANIL; UNCLASSIFIED DRUG; ATOVAQUONE; NAPHTHOQUINONE; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

CAUSE OF DEATH; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; MALARIA FALCIPARUM; MENTAL DISEASE; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT OUTCOME; DRUG COMBINATION; MALARIA; NOTE; AFRICA; DRUG RESISTANCE; RISK; ADULT; CHILD;

ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; DRUG COMBINATIONS; HUMANS; MALARIA; MEFLOQUINE; NAPHTHOQUINONES; AFRICA; CHLOROQUINE; DRUG RESISTANCE; PYRIMETHAMINE; RISK; SULFADOXINE; ADULT; CHILD; DRUG THERAPY, COMBINATION; MALARIA, FALCIPARUM;

EID: 22844438999     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200507283530421     Document Type: Letter

References (0)